Oct 7 (Reuters) - Klaria Pharma Holding AB (publ)
KLAR.ST :
* SIGNED AN AGREEMENT WITH SPANISH BIOPHARMACEUTICAL
COMPANY
PHARMAMAR
* HAS SIGNED AGREEMENT WITH AIM OF CARRYING OUT DEVELOPMENT
OF
ALGINATE FILM FORMULATION OF PHARMAMAR COMPOUND
* RESEARCH IS EXPECTED TO TAKE APPROXIMATELY 1 YEAR
* IF WORK ON DEVELOPMENT OF FORMULATION IS SUCCESSFUL,
PARTIES
INTEND TO NEGOTIATE LICENSING AGREEMENT THAT WILL GIVE PHARMAMAR
GLOBAL RIGHTS TO PRODUCT
Source text for Eikon: ID:nWkr9WmKw7
Further company coverage: KLAR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))